Found 470 articles for: "atopic dermatitis"
FULL SUPPLEMENT: Real-World Experience Integrating Ceramide-Containing Cleansers And Moisturizers Into Prescription Treatment and Maintenance for Pediatric Patients With Atopic Dermatitis
December 2023 | Volume 22 | Issue 12 | Department | SF389716s2 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposition....
Read MoreINDIVIDUAL ARTICLE: Pediatric Atopic Dermatitis Patient Cases Integrating Ceramides-Containing Cleansers and Moisturizers into Prescription Treatment and Maintenance Approaches
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF389716s3 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposi...
Read MoreNot So Vanilla: What Dermatologists Should Know About Vanilloid Receptors
December 2023 | Volume 22 | Issue 12 | Features | 1237 | Copyright © December 2023
Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis
December 2023 | Volume 22 | Issue 12 | Original Article | 1160 | Copyright © December 2023
Background: Porokeratosis is a group of disorders characterized by aberrant skin keratinization secondary to genetic alterations in the mevalonate pathway, which participates in ...
Read MoreInnate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review
December 2023 | Volume 22 | Issue 12 | Original Article | 1197 | Copyright © December 2023
Background: Candida albicans is an opportunistic pathogenic yeast commensal in human mucosa. In individuals with compromised immune systems, it can present as chronic mu...
Read MoreA Pilot Study to Evaluate the Efficacy and Tolerability of a Topical Combination Serum for the Improvement of Aged Skin
December 2023 | Volume 22 | Issue 12 | Original Article | 1204 | Copyright © December 2023
Background: With intrinsic aging, the epidermis becomes thinner and fine wrinkles appear. Extrinsic aging, or photoaging, is characterized by deep wrinkles, skin laxity, and hype...
Read MoreTopical Moisturizer Meaningfully Reduces Disease Severity in Atopic Patients With Xerosis
December 2023 | Volume 22 | Issue 12 | Editorials | e51 | Copyright © December 2023
Background: Repairing the epidermal barrier is critically important in atopic dermatitis (AD), but the effect of moisturizer on quality of life (QOL) is not well characterized.&n...
Read MoreEvaluating Quality and Reliability of Most-Viewed YouTube Videos on Topical Steroid Withdrawal
November 2023 | Volume 22 | Issue 11 | Features | 1128 | Copyright © November 2023
Epidemiology of Chronic Dermatologic Conditions in Skin of Color
November 2023 | Volume 22 | Issue 11 | Features | e21 | Copyright © November 2023
Across the board, common dermatologic conditions disproportionately affect patients of color. While the causes of these disparities have been tied to the environment, societal structure, access t...
Read MoreFULL SUPPLEMENT: The Importance of Skincare in Eczema: A Novel Over-the-Counter Routine Improves Signs and Symptoms in Patients with Eczema
October 2023 | Volume 22 | Issue 10 | Department | SF388641s1 | Copyright © October 2023
In the United States, the National Eczema Association estimates that 1 out of every 10 people have some form of eczema over their lifetime. As any dermatologist can attest, managing patients with...
Read MoreIndividual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s10 | Copyright © October 2023
Background: Study to compare efficacy, tolerability, and patient perception between an over-the-counter itch relief gel (IRG) and itch relief moisturizing cream (IRMC) after a si...
Read MoreIndividual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s21 | Copyright © October 2023
Background: Eczema, or atopic dermatitis (AD), is a chronic relapsing skin disease associated with unpredictable flares of erythema, rash, and pruritus. AD arises from a combinat...
Read MoreIndividual Article: Over-the-Counter Moisturizers Significantly Improve Skin Hydration in Adults With Eczema/Atopy-Prone Skin
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s16 | Copyright © October 2023
Background: Many adults suffer from dry, itchy skin, particularly those with eczema-prone skin. This study evaluated the effects of two over-the-counter (OTC) moisturizing produc...
Read MoreIndividual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s5 | Copyright © October 2023
Background: Eczema (also called atopic dermatitis) is a chronic, relapsing skin disease characterized by erythema, scaling, and pruritus.
Methods: Study 1....
Read MoreA Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development
October 2023 | Volume 22 | Issue 10 | Original Article | 1021 | Copyright © October 2023
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent nodules and abscesses leading to subsequent scarring and tunnel form...
Read MoreSuccessful Treatment of Lichen Planus With Oral Upadacitinib
October 2023 | Volume 22 | Issue 10 | Case Reports | 1058 | Copyright © October 2023
Lichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 There are several trea...
Read MoreSelection of Nemolizumab Clinical Dosage for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Original Article | 1017 | Copyright © October 2023
Nemolizumab is a monoclonal antibody directed against the interleukin-31 receptor A subunit, which is involved in the pathogenesis of pruritus and inflammation in atopic dermatitis (AD). Clinical tria...
Read MoreParticipant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis
October 2023 | Volume 22 | Issue 10 | Editorials | 1066 | Copyright © October 2023
Atopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children...
Read MoreUnexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade
October 2023 | Volume 22 | Issue 10 | Editorials | 1007 | Copyright © October 2023
In 2017, dupilumab became the first FDA approved systemic therapy for atopic dermatitis. Since its approval, extensive clinical experience and continued research have revealed a number of unexpected e...
Read MoreAnt Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo
October 2023 | Volume 22 | Issue 10 | Original Article | 1001 | Copyright © October 2023
Background: Atopic dermatitis (AD) is a common skin condition with relatively few therapeutic alternatives. These include corticosteroids, which address inflammation but not superinfe...
Read MoreMedia and other results for: "atopic dermatitis"